|Cross-regional pharmaceutical technology transfer in China: An empirical study based on spatial interaction model|
|Jingyun Ni1; Yuanjia Hu1; Jianbo Wan1; Thomas Scherngell2; Fung Kwa3|
|Source Publication||Innovation Value Chain of Chinese Pharmaceuticals|
|Author of Source||Yitao Wang, Yuanjia Hu, Albert Wai-Kit Chan|
|Publication Place||Whitestone, New York|
|Publisher||United States-China Intellectual Property Institute Inc.|
Background: Cross-regional technology transfer has been increasingly implemented in China, and it is playing a more and more important role in Chinese drug innovation performance. However, few attempts have been made to identify determinants of cross-regional pharmaceutical technology transfer in China. This study hence aims to identify the influence of different factors in cross-regional pharmaceutical technology transfer in China and propose policy recommendations.
Methods: We employ spatial interaction model in this study to identify different kinds of factors that influence pharmaceutical technology transfer in different spatial entities. The research sample is composed of 2,076 cases of pharmaceutical patent licensing from external domain to firms in SIPO (State Intellectual Property Office of China), geographically covering 31 province-level regions in China.
Results and Discussion: R&D (research and development) input and output in the origin region and technological demand in the destination region have positive associations with the cross-regional pharmaceutical technology transfer in China. Spatial distance shows a negative regression coefficient, which reveals that pharmaceutical technology transfer is significantly affected by geographical proximity. Fully opposed spatial spillover effects are observed between R&D input and output. This difference further implies synergistic and antagonistic relationships between regions. Accordingly, some relevant strategies have been proposed to stimulate pharmaceutical technology transfer.
Conclusions: This article sheds light on main determinants on cross-regional pharmaceutical technology transfer in China based on spatial interaction model. Through empirical test, we confirmed some influence factors. Based on results, some relevant strategies have been proposed to stimulate pharmaceutical technology transfer. This study can provide some references for policy makers, technology agencies, R&D managers.
|Keyword||Cross Region Pharmaceutical Technology Transfer Influence Factors China|
|Document Type||Book chapter|
|专题||Institute of Chinese Medical Sciences|
DEPARTMENT OF ECONOMICS
|Affiliation||1.State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau SAR, China|
2.Innovation Systems Department, AIT Austrian Institute of Technology, Austria
3.Department of Economics, Faculty of Social Sciences, University of Macau, Macau SAR, China
|First Author Affilication||Institute of Chinese Medical Sciences|
|Jingyun Ni,Yuanjia Hu,Jianbo Wan,et al. Cross-regional pharmaceutical technology transfer in China: An empirical study based on spatial interaction model. Whitestone, New York:United States-China Intellectual Property Institute Inc.,2017:221-240.|
|中相似的文章 Google Scholar|
|中相似的文章 Baidu academic|
|中相似的文章 Bing Scholar|